Rossby Financial LCC Buys Shares of 1,698 Agilent Technologies, Inc. (NYSE:A)

Rossby Financial LCC purchased a new stake in Agilent Technologies, Inc. (NYSE:A) in the 4th quarter, Holdings Channel reports. The firm purchased 1,698 shares of the medical research company’s stock, valued at approximately $228,000.

Several other hedge funds have also added to or reduced their stakes in A. Sienna Gestion increased its holdings in shares of Agilent Technologies by 29.8% in the fourth quarter. Sienna Gestion now owns 78,445 shares of the medical research company’s stock worth $10,537,000 after acquiring an additional 17,991 shares in the last quarter. Sequoia Financial Advisors LLC raised its holdings in Agilent Technologies by 8.5% during the 4th quarter. Sequoia Financial Advisors LLC now owns 33,898 shares of the medical research company’s stock worth $4,554,000 after buying an additional 2,664 shares during the period. S.E.E.D. Planning Group LLC lifted its stake in Agilent Technologies by 12.7% in the fourth quarter. S.E.E.D. Planning Group LLC now owns 42,587 shares of the medical research company’s stock valued at $5,721,000 after buying an additional 4,805 shares in the last quarter. Commonwealth Equity Services LLC increased its position in shares of Agilent Technologies by 9.8% during the fourth quarter. Commonwealth Equity Services LLC now owns 43,862 shares of the medical research company’s stock worth $5,892,000 after acquiring an additional 3,915 shares in the last quarter. Finally, Daiwa Securities Group Inc. raised its holdings in shares of Agilent Technologies by 16.0% during the fourth quarter. Daiwa Securities Group Inc. now owns 49,288 shares of the medical research company’s stock worth $6,621,000 after acquiring an additional 6,802 shares during the period.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on A shares. Barclays lowered their target price on Agilent Technologies from $138.00 to $115.00 and set an “equal weight” rating for the company in a report on Thursday, April 10th. Citigroup lifted their target price on Agilent Technologies to $165.00 and gave the company a “buy” rating in a research report on Thursday, December 19th. TD Cowen boosted their target price on Agilent Technologies to $135.00 and gave the company a “buy” rating in a research note on Thursday, April 10th. StockNews.com raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Tuesday, December 24th. Finally, Robert W. Baird cut their price objective on shares of Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating on the stock in a research report on Thursday, February 27th. Seven research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, Agilent Technologies currently has an average rating of “Moderate Buy” and a consensus target price of $146.25.

Insider Activity at Agilent Technologies

In related news, Director Daniel K. Podolsky sold 1,819 shares of the business’s stock in a transaction on Monday, March 31st. The stock was sold at an average price of $116.46, for a total value of $211,840.74. Following the completion of the sale, the director now directly owns 35,737 shares in the company, valued at $4,161,931.02. The trade was a 4.84 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, VP Rodney Gonsalves sold 1,908 shares of the company’s stock in a transaction on Monday, March 17th. The shares were sold at an average price of $121.98, for a total value of $232,737.84. Following the completion of the transaction, the vice president now directly owns 21,786 shares in the company, valued at approximately $2,657,456.28. This represents a 8.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 5,638 shares of company stock worth $731,229.

Agilent Technologies Stock Performance

Shares of A stock opened at $105.19 on Tuesday. The stock has a market cap of $29.99 billion, a P/E ratio of 24.18, a P/E/G ratio of 2.89 and a beta of 1.19. The company has a fifty day moving average price of $122.90 and a two-hundred day moving average price of $133.54. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $155.35. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.20 and a quick ratio of 1.66.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, topping analysts’ consensus estimates of $1.27 by $0.04. The business had revenue of $1.68 billion during the quarter, compared to analysts’ expectations of $1.67 billion. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. As a group, equities analysts predict that Agilent Technologies, Inc. will post 5.55 EPS for the current year.

Agilent Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be paid a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a yield of 0.94%. The ex-dividend date is Tuesday, April 1st. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.76%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.